Metabolic and dispositional fate of 1,2-dibromo-2,4-dicyanobutane in the male Fischer 344 rat

Drug Metabolism and Disposition

Volumn 26, Issue 5, 1998, Pages 429-436

  Sauer, John Michael ^b   Smith, Richard L ^b   Bao, Jingqi ^b   Kattnig, Margaret J ^b   Kuester, Robert K ^b   Sipes, I Glenn ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO 2 BROMOMETHYLGLUTARONITRILE; BUTANE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DEBROMINATION; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; GROWTH INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MUTAGENICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MASS SPECTROMETRY; NITRILES; PRESERVATIVES, PHARMACEUTICAL; RATS; RATS, INBRED F344;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0031902374     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Anonymous (1994) Methyldibromoglutaronitrile: Final report. Cosmetic Ingredient Review. Washington, D.C.
2. Birnbaum LS, Decad GM and Matthews HB (1980) Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat. Toxicol Appl Pharmacol 55:342-352.
3. 13C nuclear magnetic resonance spectroscopy. Chem Res Toxicol 4:678-687.
4. Guengerich FP (1994) Mechanisms of formation of DNA adducts from ethylene dihalides, vinyl halides, and arylamines. Drug Metab Rev 26:47-66.
5. Hausen BM (1993) The sensitizing potency of Euxyl K 400 and its components 1,2-dibromo-2,4-dicyanobutane and 2-phenoxyethanol. Contact Dermatitis 28:149-153.
6. Lag M, Omichinski JG, Dybing E, Nelson SD and Soderlund EJ (1994) Mutagenic activity of halogenated propanes and propenes: Effect of bromine and chlorine positioning. Chem Biol Interact 93:73-84.
7. Livesey JC, Anders MW, Langvardt PW, Putzig CL and Reitz RH (1982) Stereochemistry of the glutathione-dependent biotransformation of vicinal-dihaloalkanes to alkenes. Drug Metab Dispos 10:201-204.
8. Matthews HB and Anderson MW (1975) The distribution and excretion of 2,4,5,2′,5′-pentachlorobiphenyl in the rat. Drug Metab Dispos 3:211-219.
9. Sauer JM, Smith RL, Bao JQ, Kattnig MJ, Kuester RK, McClure TD, Mayersohn M and Sipes IG (1997) Oral and dermal absorption, disposition kinetics and the metabolic fate of transmethyl styryl ketone in the male Fischer 344 rat. Drug Metab Dispos 25:371-378.
10. Silver EH, Kuttab SH, Hasan T and Hassan M (1982) Structural considerations in the metabolism of nitriles to cyanide in vivo. Drug Metab Dispos 10:495-498.
11. Tosti A, Vincenzi C, Trevisi P and Guerra L (1995) Euxyl K 400: Incidence of sensitization, patch test concentration and vehicle. Contact Dermatitis 33:193-195.
12. Van Duuren BL, Seidman I, Melchionne S and Kline SA (1985) Carcinogenicity bioassays of bromoacetaldehyde and bromoethanol: Potential metabolites of dibromoethane. Teratogenesis, Carcinog Mutagen 5:393-403.
13. Winter SM and Sipes IG (1993) The disposition of acrylic acid in the male Sprague-Dawley rat following oral or topical administration. Food Chem Toxicol 31:615-621.
14. 13C nuclear magnetic resonance spectroscopy. Drug Metab Dispos 20:665-672.
15. Zoetemelk CE, Oei IH, van Meeteren-Walchli B, Onkenhout W, van der Gen: A and Breimer DD (1986) Biotransformation of 1,2-dibromopropane in rats into four mercapturic acid derivatives. Drug Metab Dispos 14:601-607.